The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,429 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 16,865 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 25,410 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 12,500 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 1,759 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 25,825 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 26,243 | 348,000 | SH | SOLE | 348,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 8,670 | 127,500 | SH | SOLE | 127,500 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 13,360 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 3,747 | 177,500 | SH | SOLE | 177,500 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 4,097 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
| EVOLENT HEALTH INC | CL A | 30050B101 | 13,253 | 1,077,500 | SH | SOLE | 1,077,500 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 15,886 | 2,600,000 | SH | SOLE | 2,600,000 | 0 | 0 | ||
| FOUNDATION MEDICINE INC | COM | 350465100 | 35,464 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 11,384 | 2,730,000 | SH | SOLE | 2,730,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 2,149 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 20,265 | 515,000 | SH | SOLE | 515,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 9,614 | 44,000 | SH | SOLE | 44,000 | 0 | 0 | ||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 6,056 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 30,305 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 23,576 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 1,579 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 41,178 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 22,960 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 15,553 | 302,474 | SH | SOLE | 302,474 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 2,667 | 274,074 | SH | SOLE | 274,074 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 18,841 | 1,135,000 | SH | SOLE | 1,135,000 | 0 | 0 | ||